Molecular MR imaging of liver fibrosis: A feasibility study using rat and mouse models

Journal of Hepatology

Volumn 57, Issue 3, 2012, Pages 549-555

  Polasek, Miloslav ^a   Fuchs, Bryan C ^b   Uppal, Ritika ^a   Schühle, Daniel T ^a   Alford, Jamu K ^a   Loving, Galen S ^a   Yamada, Suguru ^b   Wei, Lan ^b   Lauwers, Gregory Y ^a   Guimaraes, Alexander R ^a   Tanabe, Kenneth K ^b   Caravan, Peter ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Carbon tetrachloride; Diethylnitrosamine; Gadolinium; Molecular imaging; Type I collagen

Indexed keywords

CARBON TETRACHLORIDE; COLLAGEN TYPE 1; DIETHYLNITROSAMINE; GADOLINIUM PENTETATE; HYDROXYPROLINE; MESSENGER RNA; PROCOLLAGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; FEASIBILITY STUDY; LIVER; LIVER FIBROSIS; MALE; MOLECULAR IMAGING; MOLECULAR PROBE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; CARBON TETRACHLORIDE; COLLAGEN TYPE I; CONTRAST MEDIA; DIETHYLNITROSAMINE; DISEASE MODELS, ANIMAL; GADOLINIUM; HALF-LIFE; HYDROXYPROLINE; LIVER; LIVER CIRRHOSIS; MAGNETIC RESONANCE IMAGING; MALE; MICE; MOLECULAR IMAGING; MOLECULAR PROBES; RATS; RATS, WISTAR;

EID: 84865136247     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.04.035     Document Type: Article

References (42)

1. J.P. Iredale Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ J Clin Invest 117 2007 539 548 (Pubitemid 46348508)
2. S.L. Friedman Mechanisms of hepatic fibrogenesis Gastroenterology 134 2008 1655 1669 (Pubitemid 351615417)
3. R. Bataller, and D.A. Brenner Liver fibrosis J Clin Invest 115 2005 209 218 (Pubitemid 40385459)
4. J.M. Hui, J.G. Kench, S. Chitturi, A. Sud, G.C. Farrell, and K. Byth Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C Hepatology 38 2003 420 427 (Pubitemid 36919863)
5. V. Ratziu, L. Bonyhay, V. Di Martino, F. Charlotte, L. Cavallaro, and M.H. Sayegh-Tainturier Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis Hepatology 35 2002 1485 1493 (Pubitemid 34966903)
6. R. Williams Global challenges in liver disease Hepatology 44 2006 521 526 (Pubitemid 44433707)
7. D. Lavanchy Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention J Clin Virol 34 2005 S1 3
8. T.L. Wright Introduction to chronic hepatitis B infection Am J Gastroenterol 101 2006 S1 6
9. J.A. Fallowfield, T.J. Kendall, and J.P. Iredale Reversal of fibrosis: no longer a pipe dream? Clin Liver Dis 10 2006 481 497 viii (Pubitemid 44895404)
10. D.S. Manning, and N.H. Afdhal Diagnosis and quantitation of fibrosis Gastroenterology 134 2008 1670 1681 (Pubitemid 351615414)
11. V. Ratziu, F. Charlotte, A. Heurtier, S. Gombert, P. Giral, and E. Bruckert Sampling variability of liver biopsy in nonalcoholic fatty liver disease Gastroenterology 128 2005 1898 1906 (Pubitemid 40824701)
12. N.H. Afdhal, and D. Nunes Evaluation of liver fibrosis: a concise review Am J Gastroenterol 99 2004 1160 1174 (Pubitemid 38917824)
13. R.P. Myers, A. Fong, and A.A. Shaheen Utilization rates, complications and costs of percutaneous liver biopsy: a population-based study including 4275 biopsies Liver Int 28 2008 705 712 (Pubitemid 351541104)
14. P. Thampanitchawong, and T. Piratvisuth Liver biopsy: complications and risk factors World J Gastroenterol 5 1999 301 304
15. P.A. Schmeltzer, and J.A. Talwalkar Noninvasive tools to assess hepatic fibrosis: ready for prime time? Gastroenterol Clin North Am 40 2011 507 521
16. S.M. Martinez, G. Crespo, M. Navasa, and X. Forns Noninvasive assessment of liver fibrosis Hepatology 53 2011 325 335
17. P.J. Clark, and K. Patel Noninvasive tools to assess liver disease Curr Opin Gastroenterol 27 2011 210 216
18. A. Baranova, P. Lal, A. Birerdinc, and Z.M. Younossi Non-Invasive markers for hepatic fibrosis BMC Gastroenterol 11 2011 91
19. E.B. Cohen, and N.H. Afdhal Ultrasound-based hepatic elastography: origins, limitations, and applications J Clin Gastroenterol 44 2010 637 645
20. J.F. Cobbold, S. Morin, and S.D. Taylor-Robinson Transient elastography for the assessment of chronic liver disease: ready for the clinic? World J Gastroenterol 13 2007 4791 4797 (Pubitemid 47496742)
21. D.C. Rockey Noninvasive assessment of liver fibrosis and portal hypertension with transient elastography Gastroenterology 134 2008 8 14 (Pubitemid 350309358)
22. M. Friedrich-Rust, M.F. Ong, S. Martens, C. Sarrazin, J. Bojunga, and S. Zeuzem Performance of transient elastography for the staging of liver fibrosis: a meta-analysis Gastroenterology 134 2008 960 974
23. Y.K. Mariappan, K.J. Glaser, and R.L. Ehman Magnetic resonance elastography: a review Clin Anat 23 2010 497 511
24. O. Rouviere, M. Yin, M.A. Dresner, P.J. Rossman, L.J. Burgart, and J.L. Fidler MR elastography of the liver: preliminary results Radiology 240 2006 440 448 (Pubitemid 44098640)
25. L. Huwart, C. Sempoux, E. Vicaut, N. Salameh, L. Annet, and E. Danse Magnetic resonance elastography for the noninvasive staging of liver fibrosis Gastroenterology 135 2008 32 40 (Pubitemid 351899024)
26. Y. Wang, D.R. Ganger, J. Levitsky, L.A. Sternick, R.J. McCarthy, and Z.E. Chen Assessment of chronic hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imaging AJR Am J Roentgenol 196 2011 553 561
27. P. Caravan, B. Das, S. Dumas, F.H. Epstein, P.A. Helm, and V. Jacques Collagen-targeted MRI contrast agent for molecular imaging of fibrosis Angewandte Chemie-International Edition 46 2007 8171 8173 (Pubitemid 350096590)
28. P.A. Helm, P. Caravan, B.A. French, V. Jacques, L. Shen, and Y. Xu Postinfarction myocardial scarring in mice. Molecular MR imaging with use of a collagen-targeting contrast agent Radiology 247 2008 788 796
29. M. Rohrer, H. Bauer, J. Mintorovitch, M. Requardt, and H.J. Weinmann Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths Invest Radiol 40 2005 715 724 (Pubitemid 41546838)
30. K. Ishak, A. Baptista, L. Bianchi, F. Callea, J. De Groote, and F. Gudat Histological grading and staging of chronic hepatitis J Hepatol 22 1995 696 699
31. P.R. Hutson, M.E. Crawford, and R.L. Sorkness Liquid chromatographic determination of hydroxyproline in tissue samples Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences 791 2003 427 430 (Pubitemid 36638776)
32. M.F. Tweedle, P. Wedeking, and K. Kumar Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate, and gadodiamide in mice and rats Invest Radiol 30 1995 372 380
33. B. Taouli, R.L. Ehman, and S.B. Reeder Advanced MRI methods for assessment of chronic liver disease AJR Am J Roentgenol 193 2009 14 27
34. J.A. Talwalkar, M. Yin, J.L. Fidler, S.O. Sanderson, P.S. Kamath, and R.L. Ehman Magnetic resonance imaging of hepatic fibrosis: emerging clinical applications Hepatology 47 2008 332 342 (Pubitemid 351171070)
35. H. Kim, C.J. Booth, A.B. Pinus, P. Chen, A. Lee, and M. Qiu Induced hepatic fibrosis in rats: hepatic steatosis, macromolecule content, perfusion parameters, and their correlations-preliminary MR imaging in rats Radiology 247 2008 696 705
36. B. Taouli, and D.M. Koh Diffusion-weighted MR imaging of the liver Radiology 254 2010 47 66
37. K. Fujimoto, T. Tonan, S. Azuma, M. Kage, O. Nakashima, and T. Johkoh Evaluation of the mean and entropy of apparent diffusion coefficient values in chronic hepatitis C: correlation with pathologic fibrosis stage and inflammatory activity grade Radiology 258 2011 739 748
38. D.A. Aguirre, C.A. Behling, E. Alpert, T.I. Hassanein, and C.B. Sirlin Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging Radiology 239 2006 425 437
39. T. Tamada, K. Ito, A. Higaki, K. Yoshida, A. Kanki, and T. Sato Gd-EOB-DTPA-enhanced MR imaging: evaluation of hepatic enhancement effects in normal and cirrhotic livers Eur J Radiol 80 2011 e311 316
40. H. Watanabe, M. Kanematsu, S. Goshima, H. Kondo, M. Onozuka, and N. Moriyama Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging-preliminary observations Radiology 259 2011 142 150
41. S.B. Reeder, I. Cruite, G. Hamilton, and C.B. Sirlin Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy J Magn Reson Imaging 34 2011 729 749
42. S. Kiryu, Y. Inoue, K. Yoshikawa, M. Shimada, M. Watanabe, and K. Ohtomo Diet and gastrointestinal signal on T1-weighted magnetic resonance imaging of mice Magn Reson Imaging 28 2010 273 280